| abstract |
The present invention relates to an antibody specifically binding to mesothelin (MSLN), a nucleic acid encoding the antibody, a vector containing the nucleic acid and a host cell, a method for producing the antibody, Or tumor therapy. Antibodies specifically binding to mesothelin according to the present invention enable the development of antibodies that can be effectively used for the treatment or diagnosis of cancer or tumor diseases due to high affinity and specificity for the antigen . |